United States
Germany
Japan
United Kingdom
China
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (benufutamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Macaque, Cynomolgus |
Primary Antibodies
Anti-IL-13 Reference Antibody (dectrekumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque, Cynomolgus |
Anti-CD19 Reference Antibody (obexelimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus, Macaque |
Anti-GCGR Reference Antibody (crotedumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Rat, Macaque, Cynomolgus |
Anti-PDCD1 / PD-1 / CD279 Reference Antibody (penpulimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque |
Anti-TNFRSF5 / CD40 Reference Antibody (iscalimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque, Cynomolgus |
Anti-CCL5 / RANTES Reference Antibody (VLST-002)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus, Macaque |
Anti-TIGIT Reference Antibody (vibostolimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque, Cynomolgus |
Anti-MASP2 Reference Antibody (narsoplimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Rat, Macaque, Cynomolgus |
Anti-CD38 Reference Antibody (daratumumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus, Macaque |
Anti-CSF2 / GM-CSF Reference Antibody (namilumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque, Cynomolgus |
Anti-TFPI Reference Antibody (concizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque, Rabbit |
Anti-Complement C5 Reference Antibody (ravulizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Macaque, Cynomolgus |
Anti-TNFSF7 / CD27L / CD70 Reference Antibody (cusatuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Macaque, Cynomolgus |
Anti-IFNa1 Reference Antibody (sifalimumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus, Macaque |
活动过滤器
优化搜索结果
Category
Target Symbol
- INTERFERON GAMMA (5)
- CD38 (3)
- CCL5 / RANTES (2)
- CD16 (2)
- CD19 (2)
- IFNA1 (2)
- IL-18 (2)
- IL-2RA / CD25 (2)
- IL-6 / IFNB2 (2)
- IL5 (2)
- MU5AC (2)
- NCR1 (2)
- CCL20 (1)
- CCR5 / CD195 (1)
- COMPLEMENT C5 (1)
- CSF1R / M-CSFR / CD115 (1)
- CSF2 / GM-CSF (1)
- CXC-ELR (1)
- CXCL10 / IP-10 (1)
- CXCR4 / CD184 (1)
- EPHB4 (1)
- GCGR (1)
- GPC3 / GLYPICAN-3 (1)
- GPR48 (1)
- IGE (1)
- IL-13 (1)
- IL-1B (1)
- IL-22RA (1)
- IL-2RB / CD122 (1)
- INTEGRIN AL / ITGAL / CD11A (1)
- INTEGRIN B7 / ITGB7 (1)
- KLOTHO BETA (1)
- LGR4 (1)
- MASP2 (1)
- MEFLIN (1)
- NKG2A / CD94 (1)
- PDCD1 / PD-1 / CD279 (1)
- RHD / CD240D (1)
- SIRPG / CD172G (1)
- TFPI (1)
- TFR (1)
- TIGIT (1)
- TNFRSF10B / TRAILR2 / CD262 (1)
- TNFRSF4 / OX40 / CD134 (1)
- TNFRSF5 / CD40 (1)
- TNFRSF7 / CD27 (1)
- TNFSF2 / TNFA (1)
- TNFSF4 / OX40L / CD252 (1)
- TNFSF5 / CD40L / CD154 (1)
- TNFSF7 / CD27L / CD70 (1)
Applications
Antibody Hosts
Expression Hosts
Conjugates
Modifications
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. (1)
Isotypes
Assay Types
Pathways
- Allograft rejection (7)
- Cytokine-cytokine receptor interaction (7)
- Jak-STAT signaling pathway (7)
- T cell receptor signaling pathway (7)
- Graft-versus-host disease (5)
- Natural killer cell mediated cytotoxicity (5)
- Proteasome (5)
- Regulation of autophagy (5)
- Systemic lupus erythematosus (5)
- TGF-beta signaling pathway (5)
- Type I diabetes mellitus (5)
- Asthma (2)
- Autoimmune thyroid disease (2)
- Fc epsilon RI signaling pathway (2)
- Hematopoietic cell lineage (2)
